Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Nov 27, 2025; 17(11): 112060
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112060
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.112060
Association between metabolic dysfunction-associated steatotic liver disease, vitamin D3, and diabetic gastric motility disorders in type 2 diabetes mellitus
Xu Cui, Department of Pediatric Surgery, Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), Fuzhou 350005, Fujian Province, China
Xu Cui, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350112, Fujian Province, China
Zheng Liang, Institute of Transformation Studies, Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), Fuzhou 350005, Fujian Province, China
Co-first authors: Xu Cui and Zheng Liang.
Author contributions: Cui X participated in the conception of research ideas, literature retrieval and analysis, drafted and revised the core viewpoints of the letter (including questioning of exclusion criteria, elaboration of relevant mechanisms, and analysis of the association between vitamin D3 and metabolic pathways); Zheng L participated in the screening and argumentation of key literatures, conducted supplementary revisions on the mechanism of action of vitamin D3 in metabolism-related diseases and the section of research design suggestions, and assisted in refining the logical flow and academic expression of the letter, they contributed equally to this manuscript and are co-first authors.
Supported by Fujian Provincial Science and Technology Innovation Joint Fund Project, No. 2024Y9555; Youth Research Project of the Science and Technology Plan of Fujian Provincial Health Commission, No. 2024QNB005; Fujian Provincial Natural Science Foundation Project, No. 2024J011124; and Fujian Provincial Medical Project for Creating Dual High-Quality Development (High Level and High Standard), No. ETK2025004.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xu Cui, PhD, FRCS (Gen Surg), Department of Pediatric Surgery, Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), No. 18 Daoshan Road, Fuzhou 350005, Fujian Province, China. 16802937@qq.com
Received: July 17, 2025
Revised: August 18, 2025
Accepted: October 17, 2025
Published online: November 27, 2025
Processing time: 132 Days and 23.8 Hours
Revised: August 18, 2025
Accepted: October 17, 2025
Published online: November 27, 2025
Processing time: 132 Days and 23.8 Hours
Core Tip
Core Tip: This letter discusses a study linking metabolic dysfunction-associated steatotic liver disease, vitamin D3, and diabetic gastric motility disorders in type 2 diabetes mellitus, suggests refining exclusion criteria, highlights vitamin D3’s roles in metabolism and smooth muscle function, and proposes correlating metabolic dysfunction-associated steatotic liver disease severity with vitamin D3 and motility disorders, while anticipating deeper exploration of vitamin D3’s physiological functions via metabolic pathways.